Survanta Endotracheopulmonary Instillation, Suspension 25Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Survanta: Endotracheopulmonary instillation, suspension (25mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

BERACTANT is a lung surfactant. Our bodies need lung surfactant to keep the lungs open during breathing. This medicine is used to prevent and to treat Respiratory Distress Syndrome (RDS) in babies who are born early.

In-Depth Information

Survanta 25mg/ml Intratracheal Suspension

NDC: 000741040
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Neonatal Respiratory Distress Syndrome (RDS)

Sometimes used for but not FDA approved for the following conditions:
Acute Respiratory Distress Syndrome (ARDS)

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Store in original container
Discard unused portion. Do not store for later use.
Survanta 25mg/ml Intratracheal Suspension

Reported Side Effects for Survanta 25mg/ml Intratracheal Suspension

High Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Pale Skin Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Peripheral Vasoconstriction Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Infection Incidence:
10.2%*
Severity: MILD
Onset: DELAYED
Slow Heart Beat Incidence:
11.9%*
Severity: SEVERE
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Survanta

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5